RxSight (RXST) Market Capitalization (2021 - 2026)

RxSight (RXST) has reported Market Capitalization for 6 consecutive years, with $200.4 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 62.31% year-over-year to $200.4 million; the trailing twelve-month figure through Jun 2026 stood at $200.4 million (down 62.31% YoY), and the FY2025 full-year result was $429.7 million, down 69.08% from the prior year.
• Market Capitalization slipped to $200.4 million in Q2 2026 per RXST's latest filing, from $254.9 million in the prior quarter.
• Across five years, Market Capitalization topped out at $2.4 billion in Q2 2024 and bottomed at $200.4 million in Q2 2026.
• Historically, Market Capitalization has averaged $886.0 million across 5 years, with a median of $549.2 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Market Capitalization soared 306.84% in 2023, then tumbled 81.44% in 2025.
• Over 5 years, Market Capitalization stood at $358.2 million in 2022, then soared by 306.84% to $1.5 billion in 2023, then fell by 4.61% to $1.4 billion in 2024, then slumped by 69.08% to $429.7 million in 2025, then sank by 53.36% to $200.4 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $200.4 million, $254.9 million, and $429.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.